{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:11:42Z","timestamp":1777489902182,"version":"3.51.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010802","name":"Zabol University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.ZBMU.REC.1404.035"],"award-info":[{"award-number":["IR.ZBMU.REC.1404.035"]}],"id":[{"id":"10.13039\/501100010802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10787-025-01937-1","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:01:34Z","timestamp":1759035694000},"page":"5719-5733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analgesic and anti-inflammatory properties of carbenoxolone: a review"],"prefix":"10.1007","volume":"33","author":[{"given":"Hamid","family":"Ahmadpourmir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hananeh","family":"Mohammadi Tabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Gholamnezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahideh","family":"Ghorani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Faezeh","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tsarouhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Hashemzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7567-6142","authenticated-orcid":false,"given":"Ramin","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"issue":"10","key":"1937_CR1","first-page":"1155","volume":"117","author":"A Archambault","year":"1977","unstructured":"Archambault A, Farley A, Gosselin D, Martin F, Birkett J (1977) Evaluation of Duogastrome (carbenoxolone sodium) for the treatment of duodenal ulcer: a multicentre study. Can Med Assoc J 117(10):1155\u20131159","journal-title":"Can Med Assoc J"},{"issue":"5","key":"1937_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1210\/endo-111-5-1683","volume":"111","author":"D Armanini","year":"1982","unstructured":"Armanini D, Karbowiak I, Krozowski Z, Funder JW, Adam WR (1982) The mechanism of mineralocorticoid action of carbenoxolone. Endocrinology 111(5):1683\u20131686. https:\/\/doi.org\/10.1210\/endo-111-5-1683","journal-title":"Endocrinology"},{"issue":"8","key":"1937_CR3","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1097\/00003246-200008000-00044","volume":"28","author":"A Ayala","year":"2000","unstructured":"Ayala A, Song GY, Chung CS, Redmond KM, Chaudry IH (2000) Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit Care Med 28(8):2949\u20132955. https:\/\/doi.org\/10.1097\/00003246-200008000-00044","journal-title":"Crit Care Med"},{"issue":"2","key":"1937_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","volume":"139","author":"AI Basbaum","year":"2009","unstructured":"Basbaum AI, Bautista DM, Scherrer G, Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139(2):267\u2013284. https:\/\/doi.org\/10.1016\/j.cell.2009.09.028","journal-title":"Cell"},{"issue":"2","key":"1937_CR5","doi-asserted-by":"publisher","first-page":"e1066","DOI":"10.1097\/PR9.0000000000001066","volume":"8","author":"G Baskozos","year":"2023","unstructured":"Baskozos G, H\u00e9bert HL, Pascal MM, Themistocleous AC, Macfarlane GJ, Wynick D, Bennett DL, Smith BH (2023) Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK biobank. Pain Rep 8(2):e1066. https:\/\/doi.org\/10.1097\/PR9.0000000000001066","journal-title":"Pain Rep"},{"issue":"3","key":"1937_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pain.2006.02.002","volume":"122","author":"MI Bennett","year":"2006","unstructured":"Bennett MI, Smith BH, Torrance N, Lee AJ (2006) Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 122(3):289\u2013294. https:\/\/doi.org\/10.1016\/j.pain.2006.02.002","journal-title":"Pain"},{"issue":"1","key":"1937_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/j.pain.0000000000001363","volume":"160","author":"MI Bennett","year":"2019","unstructured":"Bennett MI, Kaasa S, Barke A, Korwisi B, Rief W, Treede RD (2019) The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. Pain 160(1):38\u201344. https:\/\/doi.org\/10.1097\/j.pain.0000000000001363","journal-title":"Pain"},{"issue":"5","key":"1937_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/jps.2600790510","volume":"79","author":"J Blanchard","year":"1990","unstructured":"Blanchard J, Tang LM, Earle ME (1990) Reevaluation of the absorption of carbenoxolone using an in situ rat intestinal technique. J Pharm Sci 79(5):411\u2013414. https:\/\/doi.org\/10.1002\/jps.2600790510","journal-title":"J Pharm Sci"},{"issue":"10","key":"1937_CR9","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.pain.2014.07.024","volume":"155","author":"D Bravo","year":"2014","unstructured":"Bravo D, Ibarra P, Retamal J, Pelissier T, Laurido C, Hernandez A, Constandil L (2014) Pannexin 1: a novel participant in neuropathic pain signaling in the rat spinal cord. Pain 155(10):2108\u20132115. https:\/\/doi.org\/10.1016\/j.pain.2014.07.024","journal-title":"Pain"},{"key":"1937_CR10","doi-asserted-by":"publisher","first-page":"108868","DOI":"10.1016\/j.biopha.2019.108868","volume":"115","author":"Y Chen","year":"2019","unstructured":"Chen Y, Qian Q, Yu J (2019) Carbenoxolone ameliorates insulin sensitivity in obese mice induced by high fat diet via regulating the I\u03baB-\u03b1\/NF-\u03baB pathway and NLRP3 inflammasome. Biomed Pharmacother 115:108868. https:\/\/doi.org\/10.1016\/j.biopha.2019.108868","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1937_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000505333","volume":"27","author":"Y Chen","year":"2020","unstructured":"Chen Y, Hu Z, Li R, Qiu W, Hu X, Zhou Z (2020) The effects of carbenoxolone against experimental autoimmune encephalomyelitis in a mouse model. NeuroImmunoModulation 27(1):19\u201327. https:\/\/doi.org\/10.1159\/000505333","journal-title":"NeuroImmunoModulation"},{"key":"1937_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1385\/1-59259-770-X:203","volume":"99","author":"JM Chung","year":"2004","unstructured":"Chung JM, Kim HK, Chung K (2004) Segmental spinal nerve ligation model of neuropathic pain. Pain Res Method Protocol 99:35\u201345. https:\/\/doi.org\/10.1385\/1-59259-770-X:203","journal-title":"Pain Res Method Protocol"},{"issue":"2","key":"1937_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/gut.11.2.167","volume":"11","author":"J Cliff","year":"1970","unstructured":"Cliff J, Milton-Thompson G (1970) A double-blind trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer. Gut 11(2):167\u2013170. https:\/\/doi.org\/10.1136\/gut.11.2.167","journal-title":"Gut"},{"key":"1937_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.brainres.2008.10.030","volume":"1247","author":"M Cond\u00e9s-Lara","year":"2009","unstructured":"Cond\u00e9s-Lara M, Rojas-Piloni G, Mart\u00ednez-Lorenzana G, L\u00f3pez-Hidalgo M, Rodr\u00edguez-Jim\u00e9nez J (2009) Hypothalamospinal oxytocinergic antinociception is mediated by GABAergic and opiate neurons that reduce A-delta and C fiber primary afferent excitation of spinal cord cells. Brain Res 1247:38\u201349. https:\/\/doi.org\/10.1016\/j.brainres.2008.10.030","journal-title":"Brain Res"},{"issue":"3","key":"1937_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/sti.60.3.178","volume":"60","author":"G Csonka","year":"1984","unstructured":"Csonka G, Tyrrell D (1984) Treatment of herpes genitalis with carbenoxolone and cicloxolone creams: a double blind placebo controlled clinical trial. Sex Transm Infect 60(3):178\u2013181. https:\/\/doi.org\/10.1136\/sti.60.3.178","journal-title":"Sex Transm Infect"},{"issue":"3","key":"1937_CR16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S0022-3565(25)22217-0","volume":"246","author":"JS Davidson","year":"1988","unstructured":"Davidson JS, Baumgarten IM (1988) Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J Pharmacol Exp Ther 246(3):1104\u20131107. https:\/\/doi.org\/10.1016\/S0022-3565(25)22217-0","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1937_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0006-291X(86)90522-X","volume":"134","author":"JS Davidson","year":"1986","unstructured":"Davidson JS, Baumgarten IM, Harley EH (1986) Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem Biophys Res Commun 134(1):29\u201336. https:\/\/doi.org\/10.1016\/0006-291X(86)90522-X","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"1937_CR18","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1523\/JNEUROSCI.21-17-06635.2001","volume":"21","author":"MH De Pina-Benabou","year":"2001","unstructured":"De Pina-Benabou MH, Srinivas M, Spray DC, Scemes E (2001) Calmodulin kinase pathway mediates the K+-induced increase in gap junctional communication between mouse spinal cord astrocytes. J Neurosci 21(17):6635\u20136643. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-17-06635.2001","journal-title":"J Neurosci"},{"issue":"6056","key":"1937_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/bmj.1.6056.272","volume":"1","author":"C Descamps","year":"1977","unstructured":"Descamps C, Vandenbroucke JM, van de Ypersele Strihou C (1977) Rhabdomyolysis and acute tubular necrosis associated with carbenoxolone and diuretic treatment. Br Med J 1(6056):272. https:\/\/doi.org\/10.1136\/bmj.1.6056.272","journal-title":"Br Med J"},{"issue":"3","key":"1937_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.pain.2008.03.002","volume":"137","author":"JP Dieleman","year":"2008","unstructured":"Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC (2008) Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 137(3):681\u2013688. https:\/\/doi.org\/10.1016\/j.pain.2008.03.002","journal-title":"Pain"},{"issue":"1","key":"1937_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/gut.6.1.19","volume":"6","author":"R Doll","year":"1965","unstructured":"Doll R, Hill I, Hutton C (1965) Treatment of gastric ulcer with carbenoxolone sodium and oestrogens. Gut 6(1):19\u201324. https:\/\/doi.org\/10.1136\/gut.6.1.19","journal-title":"Gut"},{"issue":"1","key":"1937_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/gut.9.1.42","volume":"9","author":"R Doll","year":"1968","unstructured":"Doll R, Langman M, Shawdon H (1968) Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone. Gut 9(1):42\u201345. https:\/\/doi.org\/10.1136\/gut.9.1.42","journal-title":"Gut"},{"issue":"1","key":"1937_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3892\/mmr.2021.12159","volume":"24","author":"S Dong","year":"2021","unstructured":"Dong S, Zhang K, Shi Y (2021) Carbenoxolone has the potential to ameliorate acute incision pain in rats. Mol Med Rep 24(1):520. https:\/\/doi.org\/10.3892\/mmr.2021.12159","journal-title":"Mol Med Rep"},{"issue":"7","key":"1937_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.2042-7158.1970.tb10550.x","volume":"22","author":"H Downer","year":"1970","unstructured":"Downer H, Galloway R, Horwich L, Parke D (1970) The absorption and excretion of carbenoxolone in man. J Pharm Pharmacol 22(7):479\u2013487. https:\/\/doi.org\/10.1111\/j.2042-7158.1970.tb10550.x","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"1937_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.12122\/j.issn.1673-4254.2022.03.13","volume":"42","author":"J Du","year":"2022","unstructured":"Du J, Li B, Zhu C, Han J, Tong X (2022) Carbenoxolone enhances inhibitory effect of RSL3 against cisplatin-resistant testicular cancer cells by promoting ferroptosis. Nan Fang Yi Ke Da Xue Xue Bao 42(3):405\u2013410. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2022.03.13","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"4","key":"1937_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.pain.2012.01.015","volume":"153","author":"RH Dworkin","year":"2012","unstructured":"Dworkin RH, Panarites CJ, Armstrong EP, Malone DC, Pham SV (2012) Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations? Pain 153(4):869\u2013875. https:\/\/doi.org\/10.1016\/j.pain.2012.01.015","journal-title":"Pain"},{"issue":"2","key":"1937_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1351-5101.2003.00725.x","volume":"11","author":"N Finnerup","year":"2004","unstructured":"Finnerup N, Jensen T (2004) Spinal cord injury pain\u2013mechanisms and treatment. Eur J Neurol 11(2):73\u201382. https:\/\/doi.org\/10.1046\/j.1351-5101.2003.00725.x","journal-title":"Eur J Neurol"},{"issue":"2","key":"1937_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101\u2013112. https:\/\/doi.org\/10.1038\/nrm2101","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1937_CR29","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1002\/ptr.6984","volume":"35","author":"M Hashemzaei","year":"2021","unstructured":"Hashemzaei M, Rezaee R (2021) A review on pain-relieving activity of berberine. Phytother Res 35(6):2846\u20132853. https:\/\/doi.org\/10.1002\/ptr.6984","journal-title":"Phytother Res"},{"issue":"3","key":"1937_CR30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1152\/physrev.00049.2005","volume":"86","author":"PG Haydon","year":"2006","unstructured":"Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86(3):1009\u20131031. https:\/\/doi.org\/10.1152\/physrev.00049.2005","journal-title":"Physiol Rev"},{"issue":"12","key":"1937_CR31","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1136\/gut.18.12.1054","volume":"18","author":"MJ Hayes","year":"1977","unstructured":"Hayes MJ, Sprackling M, Langman MJ (1977) Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects. Gut 18(12):1054\u20131058. https:\/\/doi.org\/10.1136\/gut.18.12.1054","journal-title":"Gut"},{"issue":"6","key":"1937_CR32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1248\/bpb.b21-01100","volume":"45","author":"F He","year":"2022","unstructured":"He F, Cheng Q, Li N, Shang Y (2022) Carbenoxolone ameliorates allergic airway inflammation through NF-\u03baB\/NLRP3 pathway in mice. Biol Pharm Bull 45(6):743\u2013750. https:\/\/doi.org\/10.1248\/bpb.b21-01100","journal-title":"Biol Pharm Bull"},{"issue":"5473","key":"1937_CR33","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1136\/bmj.2.5473.1274","volume":"2","author":"L Horwich","year":"1965","unstructured":"Horwich L, Galloway R (1965) Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation. Br Med J 2(5473):1274\u20131277. https:\/\/doi.org\/10.1136\/bmj.2.5473.1274","journal-title":"Br Med J"},{"issue":"1\u20132","key":"1937_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11010-006-9143-5","volume":"289","author":"FC Howarth","year":"2006","unstructured":"Howarth FC, Qureshi MA (2006) Effects of carbenoxolone on heart rhythm, contractility and intracellular calcium in streptozotocin-induced diabetic rat. Mol Cell Biochem 289(1\u20132):21\u201329. https:\/\/doi.org\/10.1007\/s11010-006-9143-5","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1937_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/00498257109044381","volume":"1","author":"P Iveson","year":"1971","unstructured":"Iveson P, Lindup W, Parke D, Williams R (1971) The metabolism of carbenoxolone in the rat. Xenobiotica 1(1):79\u201395. https:\/\/doi.org\/10.3109\/00498257109044381","journal-title":"Xenobiotica"},{"issue":"6312","key":"1937_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"R-R Ji","year":"2016","unstructured":"Ji R-R, Chamessian A, Zhang Y-Q (2016) Pain regulation by non-neuronal cells and inflammation. Science 354(6312):572\u2013577. https:\/\/doi.org\/10.1126\/science.aaf8924","journal-title":"Science"},{"issue":"1","key":"1937_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3344\/kjp.2009.22.1.1","volume":"22","author":"D Jo","year":"2009","unstructured":"Jo D, Chapman CR, Light AR (2009) Glial mechanisms of neuropathic pain and emerging interventions. Korean J Pain 22(1):1\u201315. https:\/\/doi.org\/10.3344\/kjp.2009.22.1.1","journal-title":"Korean J Pain"},{"issue":"4","key":"1937_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3233\/NRE-2003-18408","volume":"18","author":"D Jones","year":"2003","unstructured":"Jones D, Anderson E, Galvin K (2003) Spinal cord regeneration: moving tentatively towards new perspectives. NeuroRehabilitation 18(4):339\u2013351. https:\/\/doi.org\/10.3233\/NRE-2003-18408","journal-title":"NeuroRehabilitation"},{"issue":"2","key":"1937_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pnpbp.2008.12.014","volume":"33","author":"GR Juszczak","year":"2009","unstructured":"Juszczak GR, Swiergiel AH (2009) Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Prog Neuropsychopharmacol Biol Psychiatry 33(2):181\u2013198. https:\/\/doi.org\/10.1016\/j.pnpbp.2008.12.014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"1937_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5152\/balkanmedj.2014.13099","volume":"2014","author":"M Kamalpour","year":"2014","unstructured":"Kamalpour M, Fereidoni M, Moghimi A (2014) Effects of intrathecal carbenoxolone treatment on nociception and analgesia in rat. Balkan Med J 2014(2):164\u2013172. https:\/\/doi.org\/10.5152\/balkanmedj.2014.13099","journal-title":"Balkan Med J"},{"issue":"9","key":"1937_CR41","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/cancers11091383","volume":"11","author":"A Karsch-Bluman","year":"2019","unstructured":"Karsch-Bluman A, Avraham S, Assayag M, Schwob O, Benny O (2019) Encapsulated carbenoxolone reduces lung metastases. Cancers 11(9):1383. https:\/\/doi.org\/10.3390\/cancers11091383","journal-title":"Cancers"},{"issue":"4","key":"1937_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1055\/s-2006-957894","volume":"62","author":"G Khaksa","year":"1996","unstructured":"Khaksa G, Zolfaghari ME, Dehpour AR, Samadian T (1996) Anti-inflammatory and anti-nociceptive activity of disodium glycyrrhetinic acid hemiphthalate. Planta Med 62(4):326\u2013328. https:\/\/doi.org\/10.1055\/s-2006-957894","journal-title":"Planta Med"},{"issue":"6","key":"1937_CR43","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jacc.2006.04.093","volume":"48","author":"P Kojodjojo","year":"2006","unstructured":"Kojodjojo P, Kanagaratnam P, Segal OR, Hussain W, Peters NS (2006) The effects of carbenoxolone on human myocardial conduction: a tool to investigate the role of gap junctional uncoupling in human arrhythmogenesis. J Am Coll Cardiol 48(6):1242\u20131249. https:\/\/doi.org\/10.1016\/j.jacc.2006.04.093","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1937_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neures.2006.09.014","volume":"57","author":"L Lan","year":"2007","unstructured":"Lan L, Yuan H, Duan L, Cao R, Gao B, Shen J, Xiong Y, Chen L-W, Rao Z-R (2007) Blocking the glial function suppresses subcutaneous formalin-induced nociceptive behavior in the rat. Neurosci Res 57(1):112\u2013119. https:\/\/doi.org\/10.1016\/j.neures.2006.09.014","journal-title":"Neurosci Res"},{"issue":"1","key":"1937_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0304-3959(98)00154-7","volume":"79","author":"J Li","year":"1999","unstructured":"Li J, Simone DA, Larson AA (1999) Windup leads to characteristics of central sensitization. Pain 79(1):75\u201382. https:\/\/doi.org\/10.1016\/s0304-3959(98)00154-7","journal-title":"Pain"},{"issue":"1","key":"1937_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2119\/molmed.2013.00064","volume":"19","author":"W Li","year":"2013","unstructured":"Li W, Li J, Sama AE, Wang H (2013) Carbenoxolone blocks endotoxin-induced protein kinase R (PKR) activation and high mobility group box 1 (HMGB1) release. Mol Med 19(1):203\u2013211. https:\/\/doi.org\/10.2119\/molmed.2013.00064","journal-title":"Mol Med"},{"issue":"7","key":"1937_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/gut.11.7.555","volume":"11","author":"WE Lindup","year":"1970","unstructured":"Lindup WE, Parke DV, Colin-Jones D (1970) The absorption of carbenoxolone administered orally as a positioned-release capsule. Gut 11(7):555\u2013558. https:\/\/doi.org\/10.1136\/gut.11.7.555","journal-title":"Gut"},{"key":"1937_CR48","first-page":"S1","volume":"3","author":"H Merskey","year":"1986","unstructured":"Merskey H (1986) Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the international association for the study of pain. Subcommittee on Taxonomy Pain 3:S1-226","journal-title":"Subcommittee on Taxonomy Pain"},{"issue":"1","key":"1937_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0016-5085(78)90346-3","volume":"74","author":"GS Nagy","year":"1978","unstructured":"Nagy GS (1978) Evaluation of carbenoxolone sodium in the treatment of duodenal ulcer. Gastroenterology 74(1):7\u201310. https:\/\/doi.org\/10.1016\/0016-5085(78)90346-3","journal-title":"Gastroenterology"},{"key":"1937_CR50","first-page":"185","volume":"2","author":"M Nassiri-Asl","year":"2011","unstructured":"Nassiri-Asl M, Hosseini S-S, Zangivand A-A, Rahimi-Baghdashti H, Safdari F (2011) Carbenoxolone, a gap junction blocker, enhances antinociceptive effects of morphine in formalin test in mice. Pharmacolonline 2:185\u2013192","journal-title":"Pharmacolonline"},{"issue":"4","key":"1937_CR51","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/j.1471-4159.2005.03462.x","volume":"95","author":"O Nesic","year":"2005","unstructured":"Nesic O, Lee J, Johnson KM, Ye Z, Xu GY, Unabia GC, Wood TG, McAdoo DJ, Westlund KN, Hulsebosch CE (2005) Transcriptional profiling of spinal cord injury-induced central neuropathic pain. J Neurochem 95(4):998\u20131014. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03462.x","journal-title":"J Neurochem"},{"issue":"2","key":"1937_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0266-4356(84)90026-3","volume":"22","author":"M Partridge","year":"1984","unstructured":"Partridge M, Poswillo D (1984) Topical carbenoxolone sodium in the management of herpes simplex infection. Br J Oral Maxillofac Surg 22(2):138\u2013144. https:\/\/doi.org\/10.1016\/0266-4356(84)90026-3","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1937_CR53","first-page":"109","volume":"65","author":"BM Peskar","year":"1980","unstructured":"Peskar BM (1980) Effect of carbenoxolone on prostaglandin synthesizing and metabolizing enzymes and correlation with gastric mucosal carbenoxolone concentrations. Scand J Gastroenterol Suppl 65:109\u2013114","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"4","key":"1937_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00003495-197611040-00002","volume":"11","author":"R Pinder","year":"1976","unstructured":"Pinder R, Brogden R, Sawyer PR, Speight T, Spencer R, Avery G (1976) Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs 11(4):245\u2013307. https:\/\/doi.org\/10.2165\/00003495-197611040-00002","journal-title":"Drugs"},{"issue":"12","key":"1937_CR55","doi-asserted-by":"publisher","first-page":"e50216","DOI":"10.1371\/journal.pone.0050216","volume":"7","author":"SS Prasad Sakamuri","year":"2012","unstructured":"Prasad Sakamuri SS, Sukapaka M, Prathipati VK, Nemani H, Putcha UK, Pothana S, Koppala SR, Ponday LR, Acharya V, Veetill GN, Ayyalasomayajula V (2012) Carbenoxolone treatment ameliorated metabolic syndrome in WNIN\/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats. PLoS ONE 7(12):e50216. https:\/\/doi.org\/10.1371\/journal.pone.0050216","journal-title":"PLoS ONE"},{"issue":"4","key":"1937_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2362.1983.tb00112.x","volume":"13","author":"J Rask-Madsen","year":"1983","unstructured":"Rask-Madsen J, Bukhave K, Madsen P, Bekker C (1983) Effect of carbenoxolone on gastric prostaglandin E2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation. Eur J Clin Invest 13(4):351\u2013356. https:\/\/doi.org\/10.1111\/j.1365-2362.1983.tb00112.x","journal-title":"Eur J Clin Invest"},{"issue":"1\u20133","key":"1937_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2012.06.021","volume":"691","author":"SD Rhee","year":"2012","unstructured":"Rhee SD, Kim CH, Park JS, Jung WH, Park SB, Kim HY, Bae GH, Kim TJ, Kim KY (2012) Carbenoxolone prevents the development of fatty liver in C57BL\/6-Lep ob\/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis. Eur J Pharmacol 691(1\u20133):9\u201318. https:\/\/doi.org\/10.1016\/j.ejphar.2012.06.021","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1937_CR58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0016-5085(79)90002-7","volume":"77","author":"A Robert","year":"1979","unstructured":"Robert A, Nezamis JE, Lancaster C, Hanchar AJ (1979) Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77(3):433\u2013443","journal-title":"Gastroenterology"},{"issue":"1","key":"1937_CR59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.expneurol.2010.03.002","volume":"224","author":"D-H Roh","year":"2010","unstructured":"Roh D-H, Yoon S-Y, Seo H-S, Kang S-Y, Han H-J, Beitz AJ, Lee J-H (2010) Intrathecal injection of carbenoxolone, a gap junction decoupler, attenuates the induction of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol 224(1):123\u2013132. https:\/\/doi.org\/10.1016\/j.expneurol.2010.03.002","journal-title":"Exp Neurol"},{"issue":"2","key":"1937_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pmr.2007.03.005","volume":"18","author":"G Samson","year":"2007","unstructured":"Samson G, Cardenas DD (2007) Neurogenic bladder in spinal cord injury. Phys Med Rehabil Clin N Am 18(2):255\u2013274. https:\/\/doi.org\/10.1016\/j.pmr.2007.03.005","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"1937_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuro.2020.12.015","volume":"83","author":"S Sharma","year":"2021","unstructured":"Sharma S, Saini A, Nehru B (2021) Neuroprotective effects of carbenoxolone against amyloid-beta 1\u201342 oligomer-induced neuroinflammation and cognitive decline in rats. Neurotoxicology 83:89\u2013105. https:\/\/doi.org\/10.1016\/j.neuro.2020.12.015","journal-title":"Neurotoxicology"},{"issue":"2","key":"1937_CR62","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/ALN.0b013e31829bd9e2","volume":"119","author":"R Shechter","year":"2013","unstructured":"Shechter R, Yang F, Xu Q, Cheong Y-K, He S-Q, Sdrulla A, Carteret AF, Wacnik PW, Dong X, Meyer RA (2013) Conventional and kilohertz-frequency spinal cord stimulation produces intensity-and frequency-dependent inhibition of mechanical hypersensitivity in a rat model of neuropathic pain. Anesthesiology 119(2):422\u2013432. https:\/\/doi.org\/10.1097\/ALN.0b013e31829bd9e2","journal-title":"Anesthesiology"},{"issue":"2","key":"1937_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.sc.3101116","volume":"39","author":"P Siddall","year":"2001","unstructured":"Siddall P, Loeser J (2001) Pain following spinal cord injury. Spinal Cord 39(2):63\u201373. https:\/\/doi.org\/10.1038\/sj.sc.3101116","journal-title":"Spinal Cord"},{"issue":"3S","key":"1937_CR64","doi-asserted-by":"publisher","first-page":"ES93","DOI":"10.36076\/ppj.2012\/15\/ES93","volume":"15","author":"HS Smith","year":"2012","unstructured":"Smith HS (2012) Opioids and neuropathic pain. Pain Phys 15(3S):ES93","journal-title":"Pain Phys"},{"issue":"3","key":"1937_CR65","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/cancers15030591","volume":"15","author":"RAH Snijders","year":"2023","unstructured":"Snijders RAH, Brom L, Theunissen M, van den Beuken-van Everdingen MHJ (2023) Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis. Cancers (Basel) 15(3):591. https:\/\/doi.org\/10.3390\/cancers15030591","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1937_CR66","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrneurol.2011.120","volume":"7","author":"C Solaro","year":"2011","unstructured":"Solaro C, Messmer Uccelli M (2011) Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol 7(9):519\u2013527. https:\/\/doi.org\/10.1038\/nrneurol.2011.120","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"1937_CR67","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4155\/fmc-2022-0246","volume":"15","author":"Z Song","year":"2023","unstructured":"Song Z, Zhao C, Yan J, Jiang D, Jia G (2023) Carbenoxolone disodium suppresses the migration of gastric cancer by targeting HDAC6. Future Med Chem 15(4):333\u2013344. https:\/\/doi.org\/10.4155\/fmc-2022-0246","journal-title":"Future Med Chem"},{"issue":"7","key":"1937_CR68","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jpain.2004.06.006","volume":"5","author":"LE Spataro","year":"2004","unstructured":"Spataro LE, Sloane EM, Milligan ED, Wieseler-Frank J, Schoeniger D, Jekich BM, Barrientos RM, Maier SF, Watkins LR (2004) Spinal gap junctions: potential involvement in pain facilitation. J Pain 5(7):392\u2013405. https:\/\/doi.org\/10.1016\/j.jpain.2004.06.006","journal-title":"J Pain"},{"issue":"1","key":"1937_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/cs0780049","volume":"78","author":"PM Stewart","year":"1990","unstructured":"Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CR (1990) Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Sci 78(1):49\u201354. https:\/\/doi.org\/10.1042\/cs0780049","journal-title":"Clin Sci"},{"issue":"3\u20135","key":"1937_CR70","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jsbmb.2007.03.019","volume":"104","author":"X Su","year":"2007","unstructured":"Su X, Vicker N, Lawrence H, Smith A, Purohit A, Reed MJ, Potter BV (2007) Inhibition of human and rat 11\u03b2-hydroxysteroid dehydrogenase type 1 by 18\u03b2-glycyrrhetinic acid derivatives. J Steroid Biochem Mol Biol 104(3\u20135):312\u2013320. https:\/\/doi.org\/10.1016\/j.jsbmb.2007.03.019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1937_CR71","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12035-014-8769-7","volume":"51","author":"P Thakur","year":"2015","unstructured":"Thakur P, Nehru B (2015) Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson\u2019s disease. Mol Neurobiol 51(1):209\u2013219. https:\/\/doi.org\/10.1007\/s12035-014-8769-7","journal-title":"Mol Neurobiol"},{"key":"1937_CR72","first-page":"35","volume":"65","author":"PC Thornton","year":"1980","unstructured":"Thornton PC, Papouchado M, Reed PI (1980) Carbenoxolone interactions in man\u2013preliminary report. Scand J Gastroenterol Suppl 65:35\u201339","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"5","key":"1937_CR73","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/fampra\/cmm042","volume":"24","author":"N Torrance","year":"2007","unstructured":"Torrance N, Smith BH, Watson MC, Bennett MI (2007) Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract 24(5):481\u2013485. https:\/\/doi.org\/10.1093\/fampra\/cmm042","journal-title":"Fam Pract"},{"issue":"5","key":"1937_CR74","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.pain.2012.12.022","volume":"154","author":"N Torrance","year":"2013","unstructured":"Torrance N, Ferguson JA, Afolabi E, Bennett MI, Serpell MG, Dunn KM, Smith BH (2013) Neuropathic pain in the community: more under-treated than refractory? Pain 154(5):690\u2013699. https:\/\/doi.org\/10.1016\/j.pain.2012.12.022","journal-title":"Pain"},{"issue":"2","key":"1937_CR75","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/cvr\/cvu202","volume":"104","author":"N Ueda","year":"2014","unstructured":"Ueda N, Yamamoto M, Honjo H, Kodama I, Kamiya K (2014) The role of gap junctions in stretch-induced atrial fibrillation. Cardiovasc Res 104(2):364\u2013370. https:\/\/doi.org\/10.1093\/cvr\/cvu202","journal-title":"Cardiovasc Res"},{"issue":"4","key":"1937_CR76","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O Van Hecke","year":"2014","unstructured":"Van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155(4):654\u2013662. https:\/\/doi.org\/10.1016\/j.pain.2013.11.013","journal-title":"Pain"},{"issue":"2","key":"1937_CR77","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.pain.2013.11.004","volume":"155","author":"H Wang","year":"2014","unstructured":"Wang H, Cao Y, Chiang C-Y, Dostrovsky JO, Sessle BJ (2014) The gap junction blocker carbenoxolone attenuates nociceptive behavior and medullary dorsal horn central sensitization induced by partial infraorbital nerve transection in rats. Pain 155(2):429\u2013435. https:\/\/doi.org\/10.1016\/j.pain.2013.11.004","journal-title":"Pain"},{"issue":"8","key":"1937_CR78","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0166-2236(00)01854-3","volume":"24","author":"LR Watkins","year":"2001","unstructured":"Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24(8):450\u2013455","journal-title":"Trends Neurosci"},{"issue":"2","key":"1937_CR79","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pbb.2010.09.007","volume":"97","author":"H Wei","year":"2010","unstructured":"Wei H, Hao B, Huang J-L, Ma A-N, Li X-Y, Wang Y-X, Pertovaara A (2010) Intrathecal administration of a gap junction decoupler, an inhibitor of Na+\u2013K+\u20132Cl\u2212 cotransporter 1, or a GABAA receptor agonist attenuates mechanical pain hypersensitivity induced by REM sleep deprivation in the rat. Pharmacol Biochem Behav 97(2):377\u2013383. https:\/\/doi.org\/10.1016\/j.pbb.2010.09.007","journal-title":"Pharmacol Biochem Behav"},{"key":"1937_CR80","unstructured":"WHO. (2025). Sodium reduction. Retrieved May 17 from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sodium-reduction"},{"issue":"1","key":"1937_CR81","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1749-6632.1965.tb12249.x","volume":"123","author":"R Williams","year":"1965","unstructured":"Williams R, Millburn P, Smith R (1965) The influence of enterohepatic circulation on toxicity of drugs. Ann N Y Acad Sci 123(1):110\u2013124. https:\/\/doi.org\/10.1111\/j.1749-6632.1965.tb12249.x","journal-title":"Ann N Y Acad Sci"},{"key":"1937_CR82","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2014.01.042","volume":"563","author":"Q Xu","year":"2014","unstructured":"Xu Q, Cheong Y-K, Yang F, Tiwari V, Li J, Liu J, Raja SN, Li W, Guan Y (2014) Intrathecal carbenoxolone inhibits neuropathic pain and spinal wide-dynamic range neuronal activity in rats after an L5 spinal nerve injury. Neurosci Lett 563:45\u201350. https:\/\/doi.org\/10.1016\/j.neulet.2014.01.042","journal-title":"Neurosci Lett"},{"issue":"2","key":"1937_CR83","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jpain.2012.11.002","volume":"14","author":"S-Y Yoon","year":"2013","unstructured":"Yoon S-Y, Robinson CR, Zhang H, Dougherty PM (2013) Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity. J Pain 14(2):205\u2013214. https:\/\/doi.org\/10.1016\/j.jpain.2012.11.002","journal-title":"J Pain"},{"issue":"9","key":"1937_CR84","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/jcmm.13100","volume":"21","author":"X Zhang","year":"2017","unstructured":"Zhang X, Gao S, Tanaka M, Zhang Z, Huang Y, Mitsui T, Kamiyama M, Koizumi S, Fan J, Takeda M, Yao J (2017) Carbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction. J Cell Mol Med 21(9):1791\u20131802. https:\/\/doi.org\/10.1111\/jcmm.13100","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1937_CR85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3892\/ijmm.2019.4406","volume":"45","author":"L Zhang","year":"2020","unstructured":"Zhang L, Fan ZR, Wang L, Liu LQ, Li XZ, Li L, Si JQ, Ma KT (2020) Carbenoxolone decreases monocrotaline-induced pulmonary inflammation and pulmonary arteriolar remodeling in rats by decreasing the expression of connexins in T lymphocytes. Int J Mol Med 45(1):81\u201392. https:\/\/doi.org\/10.3892\/ijmm.2019.4406","journal-title":"Int J Mol Med"},{"issue":"2\u20133","key":"1937_CR86","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejphar.2009.09.065","volume":"626","author":"J Zhou","year":"2010","unstructured":"Zhou J, Yang G, Jin S, Tao L, Yu J, Jiang Y (2010) Oxymatrine\u2013carbenoxolone sodium inclusion compound induces antinociception and increases the expression of GABAA\u03b11 receptors in mice. Eur J Pharmacol 626(2\u20133):244\u2013249","journal-title":"Eur J Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01937-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01937-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01937-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:05:36Z","timestamp":1761332736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01937-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":86,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01937-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}